XLO logo

Xilio Therapeutics, Inc.

XLO
Healthcare|Biotechnology|US
$8.62
+0.12 (+1.41%)
DCF Value
$329.92
Tangible Book / Share
$3.72
Cash / Share
$7.01
Next Earnings Report
Mar 3, 2027
EPS est. -$0.97 · Revenue est. $4.1M
Financing Filings (last 12 months)
4
Shelf registrations / offering prospectuses — latest May 27, 2026 (S-3/A). Possible dilution.

Upcoming Data Readouts (2)

Sep 2028
Est. completion
P1P2Advanced Solid Tumor
XTX301 in Patients With Advanced Solid Tumors
NCT05684965n=358
Nov 2029
Est. completion
P1P2Metastatic NSCLC - Non-Small Cell Lung Cancer
XTX501 in Patients With Metastatic Non-Small Cell Lung Cancer and Advanced Solid Tumors
NCT07688577n=180

Recent Press Releases

Xilio Therapeutics to Present at the Stifel 2026 Healthcare Conference
Nov 3, 2026 · GlobeNewsWire
Xilio Therapeutics Announces First Patient Dosed in Phase 1/2 Clinical Trial of XTX501 in Patients with Metastatic NSCLC
Oct 26, 2026 · GlobeNewsWire
Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Oct 2, 2026 · GlobeNewsWire
Xilio Therapeutics Appoints Yariv J. Houvras, M.D.
Sep 28, 2026 · GlobeNewsWire
Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Sep 2, 2026 · GlobeNewsWire
Xilio Therapeutics Reports Second Quarter 2026 Financial Results and Provides Pipeline and Business Updates
Aug 12, 2026 · GlobeNewsWire

SEC Filings (85)

Last two years from EDGAR. Insider Form 4s are on the Ownership tab.

FiledFormWhat it isLinks
Aug 14, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Aug 12, 2026S-8Employee stock planDocumentIndex
Aug 12, 202610-QQuarterly reportDocumentIndex
Aug 12, 20268-KMaterial eventDocumentIndex
Jun 12, 20268-KMaterial eventDocumentIndex
May 29, 2026EFFECTDocumentIndex
May 27, 2026S-3/AShelf registrationDocumentIndex
May 15, 2026SC 13GPassive 5%+ stakeDocumentIndex
May 15, 2026SC 13G/APassive 5%+ stakeDocumentIndex
May 15, 2026SC 13G/APassive 5%+ stakeDocumentIndex
May 15, 2026SC 13GPassive 5%+ stakeDocumentIndex
May 12, 2026S-3Shelf registrationDocumentIndex
May 12, 202610-QQuarterly reportDocumentIndex
May 12, 20268-KMaterial eventDocumentIndex
Apr 28, 2026ARSAnnual report to holdersDocumentIndex
Apr 28, 2026DEF 14AProxy / shareholder voteDocumentIndex
Apr 16, 20268-KMaterial eventDocumentIndex
Mar 23, 2026S-8Employee stock planDocumentIndex
Mar 23, 202610-KAnnual reportDocumentIndex
Mar 23, 20268-KMaterial eventDocumentIndex
Mar 12, 20268-KMaterial eventDocumentIndex
Mar 9, 20268-KMaterial eventDocumentIndex
Feb 24, 20268-KMaterial eventDocumentIndex
Feb 17, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Feb 17, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Feb 13, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Feb 12, 20268-KMaterial eventDocumentIndex
Feb 12, 2026424B5Offering prospectusDocumentIndex
Feb 12, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Feb 11, 2026424B5Offering prospectusDocumentIndex
Jan 26, 2026DEF 14AProxy / shareholder voteDocumentIndex
Jan 16, 2026PRE 14AProxy / shareholder voteDocumentIndex
Jan 8, 20268-KMaterial eventDocumentIndex
Jan 5, 20268-KMaterial eventDocumentIndex
Dec 11, 2025SC 13GPassive 5%+ stakeDocumentIndex
Nov 25, 2025S-8Employee stock planDocumentIndex
Nov 25, 20258-KMaterial eventDocumentIndex
Nov 14, 2025SC 13G/APassive 5%+ stakeDocumentIndex
Nov 14, 2025SC 13GPassive 5%+ stakeDocumentIndex
Nov 13, 202510-QQuarterly reportDocumentIndex